APO RESEARCH · REPORT
Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging
Selected research
Market Analysis & Forecast
Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Analysis and Forecast 2026-2032
Market perspective
The global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging include TÜV Rheinland AG, DNV AS, UL Solutions Inc., BSI Group, LRQA Group Limited, DEKRA SE, RINA S.p.A., SCS Global Services and Intertek Group plc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging, also provides the revenue of main regions and countries. Of the upcoming market potential for Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging revenue, projected growth trends, production technology, application and end-user industry.
Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Segment by Company
TÜV Rheinland AG
DNV AS
UL Solutions Inc.
BSI Group
LRQA Group Limited
DEKRA SE
RINA S.p.A.
SCS Global Services
Intertek Group plc
Eurofins Scientific SE
Sphera Solutions, Inc.
One Click LCA Oy
Ecochain Technologies B.V.
Trayak LLC
EarthShift Global, LLC
Quantis
Anthesis Group
ERM CVS
The Carbon Trust
China Quality Certification Centre
CTI Certification Co., Ltd.
China Certification and Inspection Group Guangdong Co., Ltd.
Fangyuan Mark Certification Group Co., Ltd.
Guangzhou CEPREI Certification Center Service Co., Ltd.
Korea Testing Certification Institute
Korea Testing Laboratory
SIRIM QAS International Sdn. Bhd.
SGS S.A.
Bureau Veritas SA
TÜV SÜD AG
Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Segment by Type
Product Carbon Footprint Assessment Services
Product Carbon Footprint Verification Services
Product Carbon Footprint Assessment and Verification Integrated Services
Product Carbon Footprint Assessment Support Services
Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Segment by Application
Primary Pharmaceutical Packaging Applications
Secondary Pharmaceutical Packaging Applications
Transport Pharmaceutical Packaging Applications
All Pharmaceutical Packaging Levels
Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Product Carbon Footprint Assessment Services
- Product Carbon Footprint Verification Services
- Product Carbon Footprint Assessment and Verification Integrated Services
- Product Carbon Footprint Assessment Support Services
Applications
- Primary Pharmaceutical Packaging Applications
- Secondary Pharmaceutical Packaging Applications
- Transport Pharmaceutical Packaging Applications
- All Pharmaceutical Packaging Levels
Companies covered
- TÜV Rheinland AG
- DNV AS
- UL Solutions Inc.
- BSI Group
- LRQA Group Limited
- DEKRA SE
- RINA S.p.A.
- SCS Global Services
- Intertek Group plc
- Eurofins Scientific SE
- Sphera Solutions, Inc.
- One Click LCA Oy
- Ecochain Technologies B.V.
- Trayak LLC
- EarthShift Global, LLC
- Quantis
- Anthesis Group
- ERM CVS
- The Carbon Trust
- China Quality Certification Centre
- CTI Certification Co., Ltd.
- China Certification and Inspection Group Guangdong Co., Ltd.
- Fangyuan Mark Certification Group Co., Ltd.
- Guangzhou CEPREI Certification Center Service Co., Ltd.
- Korea Testing Certification Institute
- Korea Testing Laboratory
- SIRIM QAS International Sdn. Bhd.
- SGS S.A.
- Bureau Veritas SA
- TÜV SÜD AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market by Type
- 1.2.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Product Carbon Footprint Assessment Services
- 1.2.3 Product Carbon Footprint Verification Services
- 1.2.4 Product Carbon Footprint Assessment and Verification Integrated Services
- 1.2.5 Product Carbon Footprint Assessment Support Services
- 1.3 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market by Application
- 1.3.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Primary Pharmaceutical Packaging Applications
- 1.3.3 Secondary Pharmaceutical Packaging Applications
- 1.3.4 Transport Pharmaceutical Packaging Applications
- 1.3.5 All Pharmaceutical Packaging Levels
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Dynamics
- 2.1 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Industry Trends
- 2.2 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Industry Drivers
- 2.3 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Industry Opportunities and Challenges
- 2.4 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Industry Restraints
3 Global Growth Perspective
- 3.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Perspective (2021-2032)
- 3.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Growth Trends by Region
- 3.2.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Size by Region (2021-2026)
- 3.2.3 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Players
- 4.1.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Players (2021-2026)
- 4.1.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Key Players Headquarters & Area Served
- 4.4 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Players, Product Type & Application
- 4.5 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market CR5 and HHI
- 4.6.3 2025 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Tier 1, Tier 2, and Tier 3
5 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Size by Type
- 5.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2032)
- 5.3 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Market Share by Type (2021-2032)
6 Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Market Size by Application
- 6.1 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2032)
- 6.3 Global Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 TÜV Rheinland AG
- 7.1.1 TÜV Rheinland AG Company Information
- 7.1.2 TÜV Rheinland AG Business Overview
- 7.1.3 TÜV Rheinland AG Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.1.4 TÜV Rheinland AG Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.1.5 TÜV Rheinland AG Recent Developments
- 7.2 DNV AS
- 7.2.1 DNV AS Company Information
- 7.2.2 DNV AS Business Overview
- 7.2.3 DNV AS Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.2.4 DNV AS Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.2.5 DNV AS Recent Developments
- 7.3 UL Solutions Inc.
- 7.3.1 UL Solutions Inc. Company Information
- 7.3.2 UL Solutions Inc. Business Overview
- 7.3.3 UL Solutions Inc. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.3.4 UL Solutions Inc. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.3.5 UL Solutions Inc. Recent Developments
- 7.4 BSI Group
- 7.4.1 BSI Group Company Information
- 7.4.2 BSI Group Business Overview
- 7.4.3 BSI Group Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.4.4 BSI Group Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.4.5 BSI Group Recent Developments
- 7.5 LRQA Group Limited
- 7.5.1 LRQA Group Limited Company Information
- 7.5.2 LRQA Group Limited Business Overview
- 7.5.3 LRQA Group Limited Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.5.4 LRQA Group Limited Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.5.5 LRQA Group Limited Recent Developments
- 7.6 DEKRA SE
- 7.6.1 DEKRA SE Company Information
- 7.6.2 DEKRA SE Business Overview
- 7.6.3 DEKRA SE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.6.4 DEKRA SE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.6.5 DEKRA SE Recent Developments
- 7.7 RINA S.p.A.
- 7.7.1 RINA S.p.A. Company Information
- 7.7.2 RINA S.p.A. Business Overview
- 7.7.3 RINA S.p.A. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.7.4 RINA S.p.A. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.7.5 RINA S.p.A. Recent Developments
- 7.8 SCS Global Services
- 7.8.1 SCS Global Services Company Information
- 7.8.2 SCS Global Services Business Overview
- 7.8.3 SCS Global Services Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.8.4 SCS Global Services Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.8.5 SCS Global Services Recent Developments
- 7.9 Intertek Group plc
- 7.9.1 Intertek Group plc Company Information
- 7.9.2 Intertek Group plc Business Overview
- 7.9.3 Intertek Group plc Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.9.4 Intertek Group plc Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.9.5 Intertek Group plc Recent Developments
- 7.10 Eurofins Scientific SE
- 7.10.1 Eurofins Scientific SE Company Information
- 7.10.2 Eurofins Scientific SE Business Overview
- 7.10.3 Eurofins Scientific SE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.10.4 Eurofins Scientific SE Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.10.5 Eurofins Scientific SE Recent Developments
- 7.11 Sphera Solutions, Inc.
- 7.11.1 Sphera Solutions, Inc. Company Information
- 7.11.2 Sphera Solutions, Inc. Business Overview
- 7.11.3 Sphera Solutions, Inc. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.11.4 Sphera Solutions, Inc. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.11.5 Sphera Solutions, Inc. Recent Developments
- 7.12 One Click LCA Oy
- 7.12.1 One Click LCA Oy Company Information
- 7.12.2 One Click LCA Oy Business Overview
- 7.12.3 One Click LCA Oy Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.12.4 One Click LCA Oy Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.12.5 One Click LCA Oy Recent Developments
- 7.13 Ecochain Technologies B.V.
- 7.13.1 Ecochain Technologies B.V. Company Information
- 7.13.2 Ecochain Technologies B.V. Business Overview
- 7.13.3 Ecochain Technologies B.V. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.13.4 Ecochain Technologies B.V. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.13.5 Ecochain Technologies B.V. Recent Developments
- 7.14 Trayak LLC
- 7.14.1 Trayak LLC Company Information
- 7.14.2 Trayak LLC Business Overview
- 7.14.3 Trayak LLC Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.14.4 Trayak LLC Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.14.5 Trayak LLC Recent Developments
- 7.15 EarthShift Global, LLC
- 7.15.1 EarthShift Global, LLC Company Information
- 7.15.2 EarthShift Global, LLC Business Overview
- 7.15.3 EarthShift Global, LLC Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.15.4 EarthShift Global, LLC Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.15.5 EarthShift Global, LLC Recent Developments
- 7.16 Quantis
- 7.16.1 Quantis Company Information
- 7.16.2 Quantis Business Overview
- 7.16.3 Quantis Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.16.4 Quantis Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.16.5 Quantis Recent Developments
- 7.17 Anthesis Group
- 7.17.1 Anthesis Group Company Information
- 7.17.2 Anthesis Group Business Overview
- 7.17.3 Anthesis Group Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.17.4 Anthesis Group Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.17.5 Anthesis Group Recent Developments
- 7.18 ERM CVS
- 7.18.1 ERM CVS Company Information
- 7.18.2 ERM CVS Business Overview
- 7.18.3 ERM CVS Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.18.4 ERM CVS Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.18.5 ERM CVS Recent Developments
- 7.19 The Carbon Trust
- 7.19.1 The Carbon Trust Company Information
- 7.19.2 The Carbon Trust Business Overview
- 7.19.3 The Carbon Trust Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.19.4 The Carbon Trust Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.19.5 The Carbon Trust Recent Developments
- 7.20 China Quality Certification Centre
- 7.20.1 China Quality Certification Centre Company Information
- 7.20.2 China Quality Certification Centre Business Overview
- 7.20.3 China Quality Certification Centre Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.20.4 China Quality Certification Centre Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.20.5 China Quality Certification Centre Recent Developments
- 7.21 CTI Certification Co., Ltd.
- 7.21.1 CTI Certification Co., Ltd. Company Information
- 7.21.2 CTI Certification Co., Ltd. Business Overview
- 7.21.3 CTI Certification Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.21.4 CTI Certification Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.21.5 CTI Certification Co., Ltd. Recent Developments
- 7.22 China Certification and Inspection Group Guangdong Co., Ltd.
- 7.22.1 China Certification and Inspection Group Guangdong Co., Ltd. Company Information
- 7.22.2 China Certification and Inspection Group Guangdong Co., Ltd. Business Overview
- 7.22.3 China Certification and Inspection Group Guangdong Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.22.4 China Certification and Inspection Group Guangdong Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.22.5 China Certification and Inspection Group Guangdong Co., Ltd. Recent Developments
- 7.23 Fangyuan Mark Certification Group Co., Ltd.
- 7.23.1 Fangyuan Mark Certification Group Co., Ltd. Company Information
- 7.23.2 Fangyuan Mark Certification Group Co., Ltd. Business Overview
- 7.23.3 Fangyuan Mark Certification Group Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.23.4 Fangyuan Mark Certification Group Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.23.5 Fangyuan Mark Certification Group Co., Ltd. Recent Developments
- 7.24 Guangzhou CEPREI Certification Center Service Co., Ltd.
- 7.24.1 Guangzhou CEPREI Certification Center Service Co., Ltd. Company Information
- 7.24.2 Guangzhou CEPREI Certification Center Service Co., Ltd. Business Overview
- 7.24.3 Guangzhou CEPREI Certification Center Service Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.24.4 Guangzhou CEPREI Certification Center Service Co., Ltd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.24.5 Guangzhou CEPREI Certification Center Service Co., Ltd. Recent Developments
- 7.25 Korea Testing Certification Institute
- 7.25.1 Korea Testing Certification Institute Company Information
- 7.25.2 Korea Testing Certification Institute Business Overview
- 7.25.3 Korea Testing Certification Institute Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.25.4 Korea Testing Certification Institute Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.25.5 Korea Testing Certification Institute Recent Developments
- 7.26 Korea Testing Laboratory
- 7.26.1 Korea Testing Laboratory Company Information
- 7.26.2 Korea Testing Laboratory Business Overview
- 7.26.3 Korea Testing Laboratory Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.26.4 Korea Testing Laboratory Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.26.5 Korea Testing Laboratory Recent Developments
- 7.27 SIRIM QAS International Sdn. Bhd.
- 7.27.1 SIRIM QAS International Sdn. Bhd. Company Information
- 7.27.2 SIRIM QAS International Sdn. Bhd. Business Overview
- 7.27.3 SIRIM QAS International Sdn. Bhd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.27.4 SIRIM QAS International Sdn. Bhd. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.27.5 SIRIM QAS International Sdn. Bhd. Recent Developments
- 7.28 SGS S.A.
- 7.28.1 SGS S.A. Company Information
- 7.28.2 SGS S.A. Business Overview
- 7.28.3 SGS S.A. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.28.4 SGS S.A. Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.28.5 SGS S.A. Recent Developments
- 7.29 Bureau Veritas SA
- 7.29.1 Bureau Veritas SA Company Information
- 7.29.2 Bureau Veritas SA Business Overview
- 7.29.3 Bureau Veritas SA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.29.4 Bureau Veritas SA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.29.5 Bureau Veritas SA Recent Developments
- 7.30 TÜV SÜD AG
- 7.30.1 TÜV SÜD AG Company Information
- 7.30.2 TÜV SÜD AG Business Overview
- 7.30.3 TÜV SÜD AG Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 7.30.4 TÜV SÜD AG Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Product Portfolio
- 7.30.5 TÜV SÜD AG Recent Developments
8 North America
- 8.1 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue (2021-2032)
- 8.2 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2032)
- 8.2.1 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2026)
- 8.2.2 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2027-2032)
- 8.3 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Share by Type (2021-2032)
- 8.4 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2032)
- 8.4.1 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2026)
- 8.4.2 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2027-2032)
- 8.5 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Share by Application (2021-2032)
- 8.6 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country
- 8.6.1 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2021-2026)
- 8.6.3 North America Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue (2021-2032)
- 9.2 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2032)
- 9.2.1 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2026)
- 9.2.2 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2027-2032)
- 9.3 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Share by Type (2021-2032)
- 9.4 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2032)
- 9.4.1 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2026)
- 9.4.2 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2027-2032)
- 9.5 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Share by Application (2021-2032)
- 9.6 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country
- 9.6.1 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2021-2026)
- 9.6.3 Europe Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue (2021-2032)
- 10.2 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2032)
- 10.2.1 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2026)
- 10.2.2 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2027-2032)
- 10.3 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Share by Type (2021-2032)
- 10.4 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2032)
- 10.4.1 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2026)
- 10.4.2 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2027-2032)
- 10.5 China Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue (2021-2032)
- 11.2 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2032)
- 11.2.1 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2026)
- 11.2.2 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2027-2032)
- 11.3 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Share by Type (2021-2032)
- 11.4 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2032)
- 11.4.1 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2026)
- 11.4.2 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2027-2032)
- 11.5 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Share by Application (2021-2032)
- 11.6 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country
- 11.6.1 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2021-2026)
- 11.6.3 Asia Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue (2021-2032)
- 12.2 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2032)
- 12.2.1 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2021-2026)
- 12.2.2 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Type (2027-2032)
- 12.3 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Share by Type (2021-2032)
- 12.4 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2032)
- 12.4.1 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2021-2026)
- 12.4.2 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Application (2027-2032)
- 12.5 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue Share by Application (2021-2032)
- 12.6 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country
- 12.6.1 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2021-2026)
- 12.6.3 SAMEA Product Carbon Footprint Assessment and Verification Services for Pharmaceutical Packaging Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst